The discriminatory ability of <scp>FibroScan</scp> liver stiffness measurement, controlled attenuation parameter, and <scp>FibroScan</scp> –aspartate aminotransferase to predict severity of liver disease in children-Reference-Cited by-同舟云学术

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan –aspartate aminotransferase to predict severity of liver disease in children

Published:2022-09-07 Issue:11 Volume:6 Page:3015-3023
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Chaidez Alexander¹,Pan Zhaoxing²,Sundaram Shikha S.¹,Boster Julia¹,Lovell Mark³,Sokol Ronald J.¹,Mack Cara L.¹⁴

Affiliation:

1. Section of Pediatric Gastroenterology, Hepatology, and Nutrition Department of Pediatrics Pediatric Liver Center Children's Hospital Colorado University of Colorado School of Medicine and Anschutz Medical Campus Aurora Colorado USA

2. Clinical and Translational Science Institute University of Colorado School of Medicine and Anschutz Medical Campus Aurora Colorado USA

3. Department of Pathology University of Colorado School of Medicine and Anschutz Medical Campus Aurora Colorado USA

4. Department of Pediatrics Medical College of Wisconsin Children's Hospital Wisconsin Milwaukee Wisconsin USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1983

Reference21 articles.